Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Complementary Medicine
•
Pediatric Oncology
•
Oncology
What is your approach to patients/parents seeking alternative or complementary treatment in pediatric oncology patients?
Related Questions
How do you approach revaccination after chemotherapy, and what labs (if any) do you use to assess immune reconstitution?
What are the main barriers you encounter in enrolling pediatric oncology patients on clinical trials?
How should clinicians approach the decision to use apixaban, or other DOACs, in pediatric patients with acute lymphoblastic leukemia or lymphoma who have additional risk factors for VTE, such as obesity or a family history of thrombosis, given the negative outcome of the PREVAPIX-ALL trial?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
What therapy would you consider for refractory pediatric HR AML with KMT2Ar to try to induce remission for transplant?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
When do you consider altering treatment for a patient with metastatic osteosarcoma who showed poor response to upfront therapy with MAP (doxorubicin, cisplatin, methotrexate) chemotherapy?
What infections should we rule out in patients who develop diarrhea on immunotherapy?
